Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by HeartFlow Holding, Inc.

HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
From HeartFlow Holding, Inc.
Via GlobeNewswire
Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces Favorable Coverage Determination for Plaque Analysis by Four Medicare Administrative Contractors
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease
From HeartFlow Holding, Inc.
Via GlobeNewswire
SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease (CAD) with FFRCT Analysis
From HeartFlow Holding, Inc.
Via GlobeNewswire
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
From HeartFlow Holding, Inc.
Via GlobeNewswire
New Data from Clinical Studies Further Validate HeartFlow’s All-in-One Portfolio of Precision Coronary Care Solutions
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
From HeartFlow Holding, Inc.
Via GlobeNewswire
New HeartFlow RoadMap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences
From HeartFlow Holding, Inc.
Via GlobeNewswire
CORRECTION -- Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
From HeartFlow Holding, Inc.
Via GlobeNewswire
Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap™ Analysis
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions
From HeartFlow Holding, Inc.
Via GlobeNewswire
HeartFlow Holding, Inc. Provides Selected Preliminary Second Quarter 2021 Financial Results and Updated Guidance for Full Year 2021
From HeartFlow Holding, Inc.
Via Business Wire
HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company
From HeartFlow Holding, Inc.
Via Business Wire
Tickers LGV
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.